Aptagen, LLC
1R6 (αSyn1-95) (ID# 10145)
RNA
αSyn1-95 (N-terminal 95-residue fragment of αSyn)
Protein
11 nM (reported value)
BLI assay with PBS incubation (8.1 mM Na2HPO4, 1.5 mM KH2PO4, 2.7 mM KCl, 14 mM NaCl, pH 7.4)
30°C
RNA pool denatured at 90 °C for 10 minutes, then quickly set to ice for 30 minutes
BLI assays show 1R6 has no affinity to C-terminal αSyn regions. In Vivo assays demonstrated therapeutic benefits of aptamer only to αSyn pathology, not to AB or tau phenotypes
5'-rCprGprAprUprCprGprCprAprGprUprCprAprCprGprUprGprCprGprGprUprUprUprGprUprGprUprCprGprCprGp-3'
29
8803.6 g/mole
253100 L/(mole·cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Murakami, K., Van Nguyen, T.H., Tsuda, L. et al. Development of an RNA aptamer as a therapeutic agent for synucleinopathies. Nat Commun 17, 7118 (2026). https://doi.org/10.1038/s41467-026-75209-z
Have your aptamer oligo synthesized
ORDER NOW



We are always looking for ways to improve. Please tell us what you think.